![Sara Thuresson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Sara Thuresson worked as Director-Clinical Operations at Oncopeptides AB. From 2021 to 2026, Ms. Thuresson worked as Head-Clinical Operations at Guard Therapeutics International AB. Ms. Thuresson completed undergraduate studies at the University of Uppsala and graduate studies at Karolinska Institutet.
Eerdere bekende functies van Sara Thuresson
| Bedrijven | Functie | Einde |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Hoofd Techniek/Wetenschap/O&O | 30-04-2026 |
| ONCOPEPTIDES AB | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Sara Thuresson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Guard Therapeutics International AB
 Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
